Editorials |
Correspondence to Donald D. Heistad, MD, ATVB Editorial Office, 609 MRC, Cardiovascular Unit, The University of Iowa, Iowa City, IA 52242. E-mail ATVB@uiowa.edu
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
When our editorship began in the spring of 1999, we summarized our goals: to publish high-quality papers, to provide timely review and publication, and to publish papers that would be of special interest to our readers. In this report, we will summarize progress toward these goals. In addition, we will summarize some new initiatives and thank several people for their help.
Publication of High-Quality Papers:
The Editors rely greatly on reviewers to advise us about the scientific validity of conclusions in manuscripts. Novelty and importance of papers is very difficult to judge, and the editors also rely heavily on the advice of expert reviewers and the Editorial Board.
One measure of importance in quality of papers is the impact factor. The latest available data (for 2001) indicate that the impact factor for Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) has increased substantially during the past year (from 5.1 to 5.8), and has increased from 3.9 to 5.8 during the three years of our editorship (Figure 1). In comparison with other journals in this area of research, ATVB continues to be extremely competitive.
| |||||||||||
Recently, we have begun to track the "immediacy index," which refers to the frequency of references to articles within the first year. The immediacy index has increased during the past several years (Figure 2).
| |||||||||||
Rapid Review and Publication
One of our major goals is to provide expert, rapid reviews of manuscripts that are submitted to ATVB. The average time from receipt of
This article has been cited by other articles:
![]() |
C. A. Bolovan-Fritts and S. A. Spector Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction Blood, January 1, 2008; 111(1): 175 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shmilovich, V. Deutsch, A. Roth, H. Miller, G. Keren, and J. George Circulating endothelial progenitor cells in patients with cardiac syndrome X Heart, September 1, 2007; 93(9): 1071 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Debidda, D. A. Williams, and Y. Zheng Rac1 GTPase Regulates Cell Genomic Stability and Senescence J. Biol. Chem., December 15, 2006; 281(50): 38519 - 38528. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Dawson, N. J. Maitland, P. Berry, A. J. Turner, and B. A. Usmani Expression and localization of endothelin-converting enzyme-1 in human prostate cancer. Experimental Biology and Medicine, June 1, 2006; 231(6): 1106 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Erami, H. Zhang, A. Tanoue, G. Tsujimoto, S. A. Thomas, and J. E. Faber Adrenergic catecholamine trophic activity contributes to flow-mediated arterial remodeling Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H744 - H753. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Bolovan-Fritts, R. N. Trout, and S. A. Spector Human Cytomegalovirus-Specific CD4+-T-Cell Cytokine Response Induces Fractalkine in Endothelial Cells J. Virol., December 1, 2004; 78(23): 13173 - 13181. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Freeman, F. McManus, E. A. Brown, L. Cherry, J. Norrie, J. E. Ramsay, P. Clark, I. D. Walker, N. Sattar, and I. A. Greer Short- and Long-Term Changes in Plasma Inflammatory Markers Associated With Preeclampsia Hypertension, November 1, 2004; 44(5): 708 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P.J. Halcox and J. E. Deanfield Beyond the Laboratory: Clinical Implications for Statin Pleiotropy Circulation, June 1, 2004; 109(21_suppl_1): II-42 - II-48. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H.P. Hilgers, P. M.H. Schiffers, W. M. Aartsen, G. E. Fazzi, J. F.M. Smits, and J. G.R. De Mey Tissue Angiotensin-Converting Enzyme in Imposed and Physiological Flow-Related Arterial Remodeling in Mice Arterioscler Thromb Vasc Biol, May 1, 2004; 24(5): 892 - 897. [Abstract] [Full Text] |
||||
![]() |
V. Rathore, M. A. Stapleton, C. A. Hillery, R. R. Montgomery, T. C. Nichols, E. P. Merricks, D. K. Newman, and P. J. Newman PECAM-1 negatively regulates GPIb/V/IX signaling in murine platelets Blood, November 15, 2003; 102(10): 3658 - 3664. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |